2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9 Puritas ≥97.0% (GC)

Description:

2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone

CAS: 32384-65-9

Aspectus: Palea Yellow Oily Liquid

Puritas: ≥97.0% (GC)

Medium Dapagliflozin (CAS: 461432-26-8) et API (CAS: 842133-18-0);

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum	2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone
Synonyma	(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)Methyl) tetrahydro-2H-pyran-2-one
CAS Number	32384-65-9
CATTUS Number	RF-PI233
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C18H42O6Si4
M. Pondus	466.87
Density	0.97
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Pallida Yellow Pinguis Liquid
Puritas / Analysis Methodus	≥97.0% (GC)
Humor (KF)	≤0.50%
Test Standard	Enterprise Standard
Consuetudinem	Medium Dapagliflozin (CAS: 461432-26-8) et API (CAS: 842133-18-0);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore

commoda:

FAQ:

Applicatio:

2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone (CAS: 32384-65-9) adhiberi solet uti materia media et rudis in synthesi chemiae et industria pharmaceutica.Praesertim haec chemica late adhibita est in consilio et synthesi portatoris sodium-glucosi inhibitores.Exempli gratia, haec substantia adhiberi potest ut materia rudis in praeparatione (1S)-1,5-Anhydro-1-c-[4-Chloro-3-[(4-ethoxylphenyl)methyl]phenyl]-D-glucitoli. , quod vulgo dicitur (CAS: 461432-26-8) ut transportatores glucosi natri dependentes ad tractandum genus diabete 2 pertinent.Praeterea, potest etiam operari ut medium ad componendum Empagliflozin, quod est novum et selectivum sodium glucosi co-portatoris-2 inhibitoris.Praeterea API (CAS: 842133-18-0), aliud sodium glucosum co-portatoris-2 inhibitoris, obtineri potest adhibitis hac substantia ut mediis.